| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.67▼ | 1.67▼ | 1.67▼ | 1.72▼ | 1.78▼ |
| MA10 | 1.68▼ | 1.69▼ | 1.70▼ | 1.76▼ | 2.04▼ |
| MA20 | 1.70▼ | 1.73▼ | 1.74▼ | 1.80▼ | 3.25▼ |
| MA50 | 1.77▼ | 1.78▼ | 1.79▼ | 2.23▼ | 7.44▼ |
| MA100 | 1.81▼ | 1.82▼ | 1.81▼ | 3.38▼ | 285.13▼ |
| MA200 | 1.82▼ | 1.89▼ | 2.03▼ | 4.74▼ | 331.06▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.006▼ | -0.008▼ | 0.025▲ | 1.309▲ |
| RSI | 30.670▼ | 30.290▼ | 31.398▼ | 30.315▼ | 31.491▼ |
| STOCH | 3.125▼ | 3.125▼ | 2.083▼ | 15.064▼ | 14.541▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -94.595▼ | -92.857▼ |
| CCI | -140.741▼ | -144.625▼ | -146.393▼ | -198.696▼ | -71.005 |
|
Wednesday, October 14, 2026 04:00 AM
Next generation multispecific technology designed to coordinate innate and adaptive immune activity within the tumor microenvironmentSEATTLE, WA / ACCESS Newswire / / Inc. (NASDAQ:APVO), a ...
|
|
Monday, August 24, 2026 02:02 AM
Aptevo Therapeutics, Inc. (NASDAQ: APVO) is currently focused on the continued clinical progress with mipletamig, a $1.5 million non-dilutive grant to advance APVO451, and the company's recently ...
|
|
Friday, August 14, 2026 04:10 PM
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(5.31) per share which beat the analyst consensus estimate of $(6.16) by 13.8 percent. This is a 96.49 percent increase over losses of $ ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/10/26 | 1.73 | 1.73 | 1.60 | 1.62 | 30,917 |
| 15/10/26 | 1.73 | 1.74 | 1.70 | 1.70 | 10,786 |
| 14/10/26 | 1.73 | 1.78 | 1.71 | 1.73 | 21,794 |
| 13/10/26 | 1.79 | 1.79 | 1.70 | 1.73 | 85,568 |
| 12/10/26 | 1.79 | 1.97 | 1.76 | 1.8363 | 257,929 |
| 09/10/26 | 1.79 | 1.81 | 1.78 | 1.79 | 6,689 |
| 08/10/26 | 1.77 | 1.84 | 1.77 | 1.80 | 26,719 |
| 07/10/26 | 1.76 | 1.85 | 1.76 | 1.84 | 12,106 |
| 06/10/26 | 1.82 | 1.92 | 1.79 | 1.795 | 35,387 |
| 05/10/26 | 1.76 | 1.85 | 1.75 | 1.80 | 28,043 |
|
|
||||
|
|
||||
|
|